Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2007
11/29/2007US20070275398 Genes involved estrogen metabolism
11/29/2007US20070275397 Detection of molecular interactions using a reduced affinity enzyme complementation reporter system
11/29/2007US20070275396 Detection of DNA hybridization with a carbon nanotube label
11/29/2007US20070275395 Tagged monomers for use in sequence determination
11/29/2007US20070275394 Nucleic acid nanostructure and method of manufacturing the same
11/29/2007US20070275393 Combinatorial libraries of proteins having the scaffold structure of C-type lectin-like domains
11/29/2007US20070275392 MicroRNA motifs
11/29/2007US20070275391 Novel g-protein coupled receptors and dna sequences thereof
11/29/2007US20070275390 Polymorphisms in fatty acid binding protein 4 (''FABP4'') gene and their associations with carcass traits
11/29/2007US20070275389 Array design facilitated by consideration of hybridization kinetics
11/29/2007US20070275388 Dendrimers that possess a single target annealing site and uses thereof
11/29/2007US20070275387 Photocleavable Fluorescent Nucleotides for Dna Sequencing on Chip Constructed by Site-Specific Coupling Chemistry
11/29/2007US20070275386 Polymorphisms in the Epidermal Growth Factor Receptor Gene Promoter
11/29/2007US20070275385 Rapid Screening Method of Translational Fusion Partners for Producing Recombinant Proteins and Translational Fusion Partners Screened Therefrom
11/29/2007US20070275384 Assessing human predisposition to a febrile seizure disorder
11/29/2007US20070275383 Novel Hybrid Probes with Heightened Luminescence
11/29/2007US20070275382 Biomarkers for the Efficacy of Somatostatin Analogue Treatment
11/29/2007US20070275381 Nucleotide sequences coding variant microsatellite markers for use as tool in diagnosing learning disabilities
11/29/2007US20070275380 Method for Distinguishing Aml Subtypes With Aberrant and Prognostically Intermediate Karyotypes
11/29/2007US20070275379 Simian Orl1 Gene and Method of Assessing Compound
11/29/2007US20070275378 Rapid Determination and Quantification of Mycoplasma Contamination Using Dna Chip Technology
11/29/2007US20070275377 Isolated Photoprotein mtClytin, and Use Thereof
11/29/2007US20070275376 Tumor-Specific Expression of Reporter Genes
11/29/2007US20070275375 Means and Method for the Detection of Target Nucleotide Sequences Using Ligation Assays With Improved Oligonucleotide Probe Pairs
11/29/2007US20070275374 Methods For Idendifying Drug Targets And Modulators Of Neurons and Compositions Comprising The Same
11/29/2007US20070275373 Method of fingerprinting tissue samples
11/29/2007US20070275372 Methods and reagents for molecular detection of HIV-1 groups M, N and O
11/29/2007US20070275371 Colorimetric sensor using polydiacetylene supramolecule
11/29/2007US20070275370 Method for detecting concentrations of a target bacterium that uses phages to infect target bacterial cells
11/29/2007US20070275369 Detection of Molecular Interactions
11/29/2007US20070275368 Posh Associated Kinases And Related Methods
11/29/2007US20070275367 Type lectin fold as a scaffold for massive sequence variation
11/29/2007US20070275108 Life Span Managment
11/29/2007US20070275099 MST1 modulation of apoptosis in cardiac tissue and modulators of MST1 for treatment and prevention of cardiac disease
11/29/2007US20070275083 ameliorating chronic renal insufficiency, hypertension, atherosclerosis, and chronic congestive heart failure
11/29/2007US20070275047 Oligonucleotides Related to Lipid Membrane Attachments
11/29/2007US20070275018 Relates to gene NcSAG4, the RNA messenger of said gene, the oligonucleotides designed based on the nucleotide sequence thereof, and to protein NcSAG4 encoded thereby, and expression vectors, for the purpose of diagnosis and vaccination for the prevention of neosporosis
11/29/2007US20070275004 Group b streptococcus antigens
11/29/2007US20070275002 Use Of Proteins And Peptides Encoded By The Genome Of A Novel Sars-Associated Coronavirus Strain
11/29/2007US20070274997 Compositions and Methods for Herpes Simplex Prophylaxis and Treatment
11/29/2007US20070274995 Cardiotrophin-1 compositions and methods for the treatment of tumor
11/29/2007US20070274990 Novel Therapeutic Targets in Cancer
11/29/2007US20070274988 Kiaa0779, Splice Variants Thereof, and Methods of Their Use
11/29/2007US20070274970 Stem Cells
11/29/2007US20070274959 In Vitro Method for the Diagnosis of Cardiovascular Functionality of Bone Marrow-Precursor Cells (Bmp) and/or Circulation Precursor Cells Derived from Blood (Bdp)
11/29/2007US20070274923 Non-invasive real-time in vivo bioluminescence imaging of local Ca2+ dynamics in living organisms
11/29/2007US20070274922 such as 2-((methylamino)methyl)quinoline-8-yl-boronic acid
11/29/2007US20070274921 Diagnostics and therapeutics for ocular disorders
11/29/2007US20070274919 Method for measuring in vivo mutation frequency at an endogenous gene locus
11/29/2007US20070274917 Pharmacologic Method Of Lowering Cholesterol Production
11/29/2007US20070274916 Method for Identifying Compounds that Affect Expression of Tryptophan Hydroxylase Isoform 2
11/29/2007US20070274915 Modulation Of Anergy And Methods For isolating Anergy-Modulating Compounds
11/29/2007US20070274914 Mptens as Modifiers of the Pten/Igf Pathway and Methods of Use
11/29/2007US20070274912 Histone Modifications as Binary Switches Controlling Gene Expression
11/29/2007DE10259834B4 Test und Screeningverfahren zur Identifizierung von Inhibitoren von Beta-Sekretasen Test and screening methods for identifying inhibitors of beta secretases
11/29/2007DE102006048264A1 Test set for the detection of specific nucleic acid sequences, comprises a probe carrier plate having a probe reaction surface, a sample carrier plate having a sample reaction surface, and a container with a fluid probe composition
11/29/2007DE102006025016A1 Use of transgenic mice in which the selenoprotein P gene is switched off heterozygotically as an animal model for simulating a serum selenium concentration within the range of the average normal concentration in humans
11/29/2007DE102006023897A1 Verfahren und Mittel zur enzymatischen Bestimmung von Ethanol Method and means for the enzymatic determination of ethanol
11/29/2007CA2653456A1 Permeability of blood-brain barrier
11/29/2007CA2653454A1 Ambient temperature stable kits for molecular diagnostics
11/29/2007CA2653052A1 Treatment of protein misfolding
11/29/2007CA2652600A1 Use of cathepsin k antagonists in bone production
11/29/2007CA2652562A1 Method for automated tissue analysis
11/29/2007CA2652558A1 Bacterial strains, compositions including same and probiotic use thereof
11/29/2007CA2652442A1 Antitumor agent for thyroid cancer
11/29/2007CA2652404A1 Detection method for influenza viruses
11/29/2007CA2652239A1 Assessment of effect of an agent on a human biological condition using rodent gene expression panels
11/29/2007CA2652087A1 A method for predicting responsiveness to tnf.alpha. blocking agents
11/29/2007CA2652052A1 Nucleic acid separation and purification method based on reversible charge interactions
11/29/2007CA2651937A1 Optical fluorescent imaging using cyanine dyes
11/29/2007CA2651709A1 Use of protein s100a 12 as a marker for colorectal cancer
11/29/2007CA2642648A1 Detection of anthrax pathogenicity factors
11/29/2007CA2590552A1 Methods and compositions for depleting mitochondrial dna
11/28/2007EP1860436A1 Blood coagulation accelerator and vessel for blood test
11/28/2007EP1860432A1 A method for operating a measuring meter and a measuring meter
11/28/2007EP1860200A1 Multiplexed methylation detection methods
11/28/2007EP1860199A2 Modulating insulin receptor signaling
11/28/2007EP1860198A1 Method and apparatus for concentrating and amplifying nucleic acid in single micro chamber
11/28/2007EP1860197A1 Method for detecting target nucleic acids using template catalyzed transfer reactions
11/28/2007EP1860196A1 Method of analyzing dynamics in the differentiation of vascular endothelial progenitor cells
11/28/2007EP1860189A1 Human gene
11/28/2007EP1860186A2 Method for distinguishing mesenchymal stem cells using different markers
11/28/2007EP1860185A1 Screening method
11/28/2007EP1860183A1 Mutant glucose dehydrogenase
11/28/2007EP1860179A1 Cell observation aiding instrument and method of cell observation therewith
11/28/2007EP1860119A1 ANTI-IgSF4 ANTIBODY AND UTILIZATION OF THE SAME
11/28/2007EP1860117A2 Anti-bacterial vaccine compositions
11/28/2007EP1860115A1 Oligonucleotide derivative, probe for detection of gene, and dna chip
11/28/2007EP1859376A2 Optimized probe selection method
11/28/2007EP1859281A1 Method and device for isolating micro-organisms
11/28/2007EP1859249A1 Apparatus and methods for concentrating and separating particles such as molecules
11/28/2007EP1859062A2 Detection of very virulent infectious bursal disease virus
11/28/2007EP1859061A1 Detection method for ljungan virus
11/28/2007EP1859060A2 Human autism susceptibility genes encoding a neurotransmitter transporter and uses thereof
11/28/2007EP1859059A2 Association between markers in the leptin gene and carcass traits in commercial feedlot steer and heifers
11/28/2007EP1859058A2 Dna crosslinking for primer extension assays
11/28/2007EP1859057A2 Improved halohydrin dehalogenases and related polynucleotides
11/28/2007EP1859056A2 Genetic basis of alzheimer's disease and diagnosis and treatment thereof
11/28/2007EP1859055A2 Use of panel of pairs of primers complementary to reporter genes of cell differentiation
11/28/2007EP1859054A2 Microarray and method for genotyping shv beta lactamases